Welcome to this week’s Pandora Report! This issue examines unanswered questions surrounding a Russian plague lab researcher’s death, persistent gaps in U.S. biodefense preparedness, and new research challenging assumptions about H5N1’s ability to infect humans.
📢 Interested in Graduate Study in Public Policy, Biodefense, or International Security?
The Schar School of Policy and Government is hosting a series of upcoming Faculty Information Sessions for prospective master’s and graduate certificate students. These interactive sessions offer a direct opportunity to learn about curriculum structure, career pathways in biodefense and policy, and the student experience at George Mason University.
Remaining Sessions:
- International Security on Tuesday, October 13, 12:00 pm ET
- Organizational Development & Knowledge Management (ODKM) on Thursday, October 15, 12:00 pm ET
A Plague Lab Worker Died in Russia. The WHO Still Wants Answers.
By Carmen Shaw, Managing Editor, The Pandora Report | PhD Biodefense, GMU
The death of a 28-year-old laboratory researcher at a Russian anti-plague research institute has raised questions from the international community about lab safety and transparency. Darya Shipilova, who worked at the Irkutsk Anti-Plague Research Institute of Siberia and Far East, died on October 2 from pneumonia of unknown origin, according to Russian authorities. Media reports have suggested that a broken test tube containing Yersinia pestis, the bacterium that causes plague, may have been involved, but this has not been independently confirmed, and Russian officials have denied that plague caused her death. Authorities initially placed approximately 200 of her contacts under quarantine or medical observation. On October 7, WHO Director-General Tedros Adhanom Ghebreyesus said that the WHO lacked sufficient information to conduct a full risk assessment and was seeking clarification about reports of a second employee with unexplained pneumonia.
Russian officials have since denied reports of a second case, stating that checks of Shipilova’s contacts found no evidence of dangerous pathogens. The cause of her death has not been definitively established publicly. Although a laboratory accident has not been confirmed and WHO has assessed the broader risk as low, the case highlights the challenges of assessing potential biological exposures when information is limited. For the biodefense community, the incident underscores the importance of transparent reporting, effective laboratory biosafety and biosecurity measures, and timely international communication when dealing with biorisks.
Further reading:
- “Officials Seek to Reassure Public After Irkutsk Anti-Plague Institute Worker’s Death,” The Moscow Times
- “Hospital in Russia’s Irkutsk region quarantined amid reports that a patient died of pneumonic plague,” Meduza
- “Irkutsk suspected plague death – WHO,” United Nations Office at Geneva
- “What Keeps Me Up at Night About the Russia Plague Scare,” Gigi Kwik Gronvall, NY Times
- “Irkutsk plague death: what Russia has told WHO, and what it hasn’t,” Céline Gounder, Underlying Conditions
- “U.S. officials seeking details of reported Russian plague death, quarantines,” Lena H. Sun, Dan Diamond and Mary Ilyushina, WP
- “Russian plague lab worker’s death raises public health, biodefense questions amid information void,” Alison Young, Health Beat
AI Biosecurity Risks Must Not Distract from Persistent Biodefense Gaps
In a new commentary for Nature, CEO of the Global Health Security Network (GHSN) and GMU’s BIOD 2019 alumna and Assistant Professor, Saskia Popescu, argues that growing concerns about AI-enabled biological threats must not overshadow longstanding vulnerabilities in biodefense and public health preparedness. Twenty-five years after the 2001 anthrax attacks, Popescu highlights persistent gaps in biosurveillance, oversight of private laboratories, bioattribution, and outbreak response. She calls for stronger government regulation, stronger monitoring processes, and robust safeguards. Read more here.
Further Reading
- “How to Defend Against AI-Designed Viruses,” Jason T. Kaelber, War on the Rocks
- “Schar School Alumnus Daniel Gerstein’s First Novel Explores the Future of Warfare,” Buzz McClain, Schar School of Policy and Government
- “What Does “Autonomous” Actually Mean in a Wet Lab?” Steph Batalis, Substack
Lentzos and Lim Challenge Worst-Case Biological Warfare Scenarios
In a new analysis for the Bulletin of the Atomic Scientists, Filippa Lentzos and Yong-Bee Lim, GMU Biodefense 2021 alum, challenge the assumptions underpinning Annie Jacobsen’s bestselling book Biological War: A Scenario. The authors argue that the book’s catastrophic scenario stacks worst-case assumptions about pathogen transmissibility, blurred distinctions between dual-use research and weaponization, and overstating what AI changes about biological weapons development, making it a somewhat narrow-minded guide for assessing plausible biological threats. Their analysis highlights the importance of evidence-based threat assessments over sensationalized scenarios when shaping biological security policy.
Fake Bird Flu Patients, Real Gaps in Preparedness
By Margeaux Malone, Pandora Report Associate Editor
A recent report published in the CDC’s Morbidity and Mortality Weekly Report (MMWR) revealed the results of unannounced drills assessing the readiness of healthcare facilities to respond to a potential infectious disease outbreak. Between January and June 2026, 73 unannounced “mystery patient” drills were conducted in emergency departments, outpatient clinics, and urgent care centers in New Jersey, New York, and the U.S. Virgin Islands. Professional actors presented with symptoms consistent with avian influenza A(H5), including simulated conjunctivitis, but without travel-related exposure.
Results were mixed. Symptom screening occurred in 93% of drills and travel history was obtained in nearly 80%, yet only 10% of the time did staff ask about exposure history specific to H5, such as contact with birds or livestock. Although fewer than half of the drills hit the target times of 1 minute for masking (43.1%) and 10 minutes for isolation (48.1%), the median times of 2 minutes and 11 minutes, respectively, were still very close. Concerningly, clinicians wore all recommended personal protective equipment (PPE) in only a quarter of encounters, and in 6% of encounters wore no PPE at all.
Overall, 44/73 drills (60.3%) were deemed successful because both patient masking and isolation were completed. The patient actor was identified as being at risk for avian influenza in 63.4% drills. Urgent care centers were slowest to mask patients, and outpatient clinics slowest to isolate them. The authors recommend role-specific training for front-line staff, such as receptionists and security, who are often first to meet patients, and updated screening protocols that reflect zoonotic exposure routes.
What Scientists Found in Canada’s First Human H5N1 Case
In November 2024, a teenager in British Columbia (B.C.) became critically ill with H5N1, Canada’s first human case. Sequencing by the B.C. Centre for Disease Control revealed two unusual mutations in the surface protein the virus uses to attach to cells. A similar mutation was later found in the Louisiana patient who died in the United States in January 2025, causing experts to speculate that these mutations may allow H5N1 to better infect humans. However, a University of British Columbia team tested that idea in a study published in Nature Communications and, surprisingly, found the opposite.
Using cryo-electron microscopy, they mapped the mutated protein at near-atomic detail and found the mutations actually weakened binding to human receptors. The protein could still trigger fusion with the cell membrane, the step that lets viral genetic material enter, though with far less efficiently than other H5N1 strains tested. The researchers suggest that many weak interactions may add up to enough attachment for infection. This case, in which the patient fully recovered, shows why infectious disease surveillance and research systems need to work together to assess emerging threats. Ongoing genetic surveillance can rapidly detect changes in a virus, and sustained laboratory capacity to investigate those changes helps scientists and public health officials separate meaningful warning signs from those that only look concerning on paper.
Further Reading
- “H5N1 avian flu returns to Midwest poultry farms, with multiple turkey operations hit,” Stephanie Soucheray, CIDRAP
- “AAP renews call for raw milk sales ban, cites emerging H5N1 risk,” Benjamin P. Saylor, Contemporary Pediatrics
- “New World screwworm cases climb to 53; new case confirmed in Brewster County dog,” Texas Public Radio
- “Bird Flu, Actors, Unannounced Drills … CDC Study Has It All,” Terrence Rudd, MedPage Today
Publication Highlights: Global Molecular Detection of Influenza
GMU Biodefense PhD student Dara Russell, MPH, has published a new article in the Armed Forces Health Surveillance Division’s Medical Surveillance Monthly Report (MSMR) comparing influenza surveillance data from the U.S. Department of War’s Global Emerging Infections Surveillance (GEIS) program with the WHO Global Influenza Surveillance and Response System (GISRS) from 2025 through 2026. Read the full September 2026 report here.
IN OTHER NEWS
Infectious Disease Outbreaks and Public Health Preparedness
- “An Ebola treatment center was burned down as the death toll in Congo passes 4,000,” Dieudonne Dirole and Ope Adetayo, Associated Press
- “Scaling up to stay ahead of the Ebola outbreak,” World Health Organization (WHO)
- “Kenya confirms its first Ebola case and death in a man who traveled from Congo,” Evelyne Musambi, Associated Press
- “New York declares first US measles disaster emergency since 2025 surge,” Reuters
- “Pennsylvania records a fifth measles death as the nation endures its worst year since 1991,” Mike Stobbe, Associated Press
- “Bridging Evidence and Action: 25 Years of Trust for America’s Health,” Trust for America’s Health (TFAH)
- “Tracking the “America First” Bilateral Health Agreements,” Anya Hirschfeld, Allison Krugman, Thomas J. Bollyky, Stephanie Psaki, Joseph L. Dieleman, Think Global Health
- “Congress allocated $1.3 billion that the trump administration hasn’t spent,” Fatma Tanis, NPR
- “Some CDC foreign offices shutting their doors as US implements ‘America First’ policy,” Mary Van Beusekom, CIDRAP
- “U.S. ends health aid to Zimbabwe after ‘America First’ deal is spurned,” Adam Taylor, The Washington Post
Chemical Weapons, Arms Control, and International Security
- “Time to Fund the OPCW,” Al Mauroni, Substack
- “Syria – Syria joins the International Partnership against Impunity for Chemical Weapons,” Ministére De L’Europe Et Des Affaires Étrangères
- “Syria chemical weapons partnership could strengthen accountability, center says,” SANA
🎙️ What We’re Listening To:
- “Face-Off: Nuclear Anarchy,” Jane Perlez, Harvard Kennedy School and Managing the Atom Project
- “Background Briefing with Ian Masters: October 8, 2026,” Background Briefing
NEW: Milbank Quarterly Webinar – State Policy Levers for Infectious Disease Control
Thursday, October 29 | 1:00 – 2:00 pm ET
From Milbank Memorial Fund: “Major infectious disease outbreaks in 2026, including a multi-state measles surge, the iceberg lettuce-linked cyclosporiasis outbreak, and the hantavirus outbreak, underscore the importance of infectious disease control infrastructure. Join us for a Milbank Quarterly webinar with the authors of two articles about state infectious disease policy from our special issue, Disease Burden, Mortality, and Life Expectancy in the United States: What Can State Policymakers Do to Meet the Challenges?”
NEW: Understanding Zoonotic Disease Risk in Violent and Conflict-Affected Places: Where Do We Go from Here? – A Talk
Friday, October 30 | 11:00 am – 12:00 pm ET
From Johns Hopkins: “The next pandemic will likely be caused by a zoonotic pathogen and will likely emerge in a place affected by conflict and violence. As such, disease spillover and spread will likely be affected by informal and extralegal economies, population displacement, distrust between people and governmental authorities, and failing health and disease surveillance systems. This talk will discuss findings and lessons learned from collaborative, interdisciplinary research on zoonotic disease risk among pastoralists in eastern Ethiopia and gather feedback on remaining questions and potential next steps.”
NEW: After NSCEB: What Comes Next for U.S. Biotech Policy
Tuesday, November 17 | 2:00 – 6:00 pm ET
From the National Security Commission on Emerging Biotechnology (NSCEB): “The Commission’s authority ends December 31. What it built is the beginning. Carrying it forward takes Congress, industry and capital. In April 2025, the Commission called for $15 billion over five years to secure American leadership in biotechnology. Join Commission leadership, members of Congress, founders and investors for an afternoon on who carries that work into 2027.”
Training Course on ‘Biotechnology Innovation and Biosecurity’
October 12-16 in New Delhi, India
From the International Centre for Genetic Engineering and Biotechnology (ICGEB) and the Biological Weapons Convention Implementation Support Unit: “This training focuses on strengthening capacities in biosecurity, biosafety, and biological risk management in the context of rapid advances in biotechnology with an integrated, interdisciplinary approach to manage biothreats at the intersection of humans, animals, plants and the environment. It addresses the governance, technical, and operational dimensions of preventing, detecting, and responding to biological threats, while promoting responsible and peaceful scientific research and innovation in accordance with Article X of the Biological Weapons Convention (BWC).”
Cross-Sector Collaborations to Counter Deliberate Biothreats – A Webinar Series
Thursday, October 22 | 8:00 – 9:00 pm Singapore Time or 8:00 – 9:00 am ET
From Asia Centre for Health Security (ACHS): “Deliberate biothreats present complex challenges that cannot be addressed by health or security sectors acting alone. Effective prevention, detection, and response to biological threats require sustained intersectoral coordination, including across public health, animal health, law enforcement, and defense. Mr. Trevor Smith will speak from his extensive experience with Global Affairs Canada’s Weapons Threat Reduction Program in international weapons of mass destruction (WMD) threat reduction initiatives. We will explore how partnerships across sectors and countries can strengthen resilient systems to counter current and emerging deliberate biothreats.”
Biomanufacturing for Defense & Security Summit
October 27-28 at the National Harbor, MD
From Diversified Solutions Incorporated (DSI Groups): “This event will bring together senior thought leaders and stakeholders from across DoW, Military Research Labs, Federal Government, Commercial Industry, & Academia to discuss how each are advancing biomanufacturing to enhance national security objectives, produce critical materials for defense applications, and strengthen the overall U.S. bioindustrial manufacturing base. Biomanufacturing is crucial for U.S. national security because it enables domestic production of critical materials, medicines, and defense supplies, reducing reliance on foreign adversaries, which in turn creates resilient supply chains for the military and economy.”
Frontiers in Synthetic Biology: SpudCells, Mirror Life and Societal Implications
Thursday, October 29, 3:00 PM ET
From the Consortium on Law and Values: “Advances in cell engineering and synthetic biology offer enormous potential benefits, while raising ethical and policy issues. SpudCell, the first synthetic cell that can grow and reproduce, built from non-living chemicals, was developed by a team at the University of Minnesota. Scientists have cautioned against creating organisms with molecules that are mirror images of the biological components of known life, as existing organisms would have no immune defenses. Join three experts on synthetic biology, biosecurity, and bioethics to explore how to realize the promise of synthetic biology while controlling potential risks.”
AI, Biosecurity, and Pandemic Preparedness in the Global South
Monday, November 2, from 8:00-9:30 AM ET
Medical Events Global is hosting a free 90-minute virtual workshop examining how artificial intelligence and emerging technologies are reshaping biological risk and what preparedness requires in the Global South. The panel will explore where biological risks are concentrated, the capabilities of AI-enabled biological design, operational preparedness, and approaches to governance. Confirmed speakers include Alex Kyabarongo, BIOD MS student at George Mason University and former member of the Biological Weapons Convention Implementation Support Unit (BWC ISU) and NTI bio team, along with Rahul Nagvekar of Stanford University’s Department of Genetics and Adam Abdullahi of the Institute of Human Virology Nigeria and Harvard T.H. Chan School of Public Health.
NEW: Chief of Staff for the Responsible AIxBio Collaboration – Job Opening
From the R-ABC: “We are a new nonprofit working to make the world a safer place by reducing the misuse risk of AI-enabled biological tools. We do that by catalyzing and accelerating governance for AI x bio: bringing into being the standards and shared resources that don’t exist yet. Our stakeholders are the world-leading frontier companies, platforms, and research groups building AI for the life sciences. We work with them directly, not around them. R-ABC was founded in 2026 and is still small.”
Fellowship for Ending Bioweapons – Call for Applications
Monday, October 19
From the Council on Strategic Risks: “Whether biological threats arise naturally, by accident, or through a deliberate effort to weaponize pathogens, risks posed by biological threats are grave risks to international security and stability. The urgency for mitigating this area of catastrophic risks is driven home by the growing convergence of artificial intelligence and biological sciences, which may simplify pathways to the development of biological weapons and can spur the creation of novel pathogens.”
Director, Global Biological Policy and Programs – Job Opening
From the Nuclear Threat Initiative (NTI): “NTI – a nonprofit, nonpartisan global security organization focused on reducing nuclear, biological, and emerging technology threats imperiling humanity – is seeking a Director to join the Global Biological Policy and Programs team. The NTI | bio team is focused on reducing catastrophic biological risks, and we are working toward this goal by strengthening biotechnology governance; bolstering biosecurity in countries around the world; strengthening international capabilities to uphold the norm against bioweapon development and use; driving progress in Global Health Security; and building the biosecurity field.”
